Keyphrases
In Cancer
100%
Intravenous Contrast
100%
Positron Emission Tomography-computed Tomography (PET-CT)
100%
Cancer Patients
100%
PET Attenuation Correction
100%
Computed Tomography
100%
Intravenous Contrast Agents
66%
Standardized Uptake Value
50%
PET Image
50%
PET Scan
50%
Attenuation Correction
33%
Clinical Evaluation
33%
Tumor
33%
Total-body PET/CT
16%
Phantom Study
16%
Attenuation Factor
16%
Nuclear Medicine
16%
CT Studies
16%
CT Data
16%
Diagnostic Quality
16%
Kappa Coefficient
16%
Clinical Value
16%
Prospective Clinical Study
16%
18F-fluorodeoxyglucose (18F-FDG)
16%
Non-tumor Tissue
16%
Contrast Agent
16%
Weighted kappa
16%
Malignant Tumor
16%
Attenuation
16%
Global Behavior
16%
Clinical Diagnostics
16%
Image-based
16%
Contrast-enhanced CT
16%
Global Standards
16%
SUVmax
16%
CT Examination
16%
Subclavian Vein
16%
Clinical Significance
16%
Combined Modality
16%
Intravenous Contrast Media
16%
Medicine and Dentistry
Positron Emission Tomography-Computed Tomography
100%
Polyethylene Terephthalate
100%
Malignant Neoplasm
100%
Contrast Medium
55%
Neoplasm
33%
Diagnosis
33%
Standardized Uptake Value
33%
positron emission tomographic scan
22%
Physician
22%
Clinical Trial
22%
Intravenous Contrast Medium
11%
Subclavian Vein
11%
Clinical Study
11%
Whole Body PET
11%
Nuclear Medicine
11%
Fluorodeoxyglucose F 18
11%
Clinical Significance
11%
Veterinary Science and Veterinary Medicine
Positron Emission Tomography-Computed Tomography
100%
Cancer
100%
Contrast Medium
71%
Neoplasm
42%
Clinical Significance
14%
Intravenous Contrast Medium
14%
Subclavian Vein
14%
Immunology and Microbiology
Positron Emission Tomography-Computed Tomography
100%
X-Ray Computed Tomography
85%
Contrast Medium
71%
positron emission tomographic scan
28%
Subclavian Vein
14%
Intravenous Contrast Medium
14%
Whole Body PET
14%